25 of the Best Oncologists Near Me

Korie Flippo is an Oncologist and a Hematologist practicing medicine in Plano, Texas. Dr. Flippo is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Multiple Myeloma, and Anemia. Dr. Flippo is board certified in Hospice & Palliative Medicine- American Board Of Internal Med/Hospice And Palliative Medicine, Hospice And Palliative Medicine- American Board Of Internal Medicine, Medical Oncology- American Board Of Internal Medicine, Hematology- American Board Of Internal Med/Hematology, Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Hematology- American Board Of Internal Medicine. Dr. Flippo is currently accepting new patients.

Seyfettin Alpdogan is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Alpdogan is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Cutaneous T-Cell Lymphoma (CTCL), Multiple Myeloma, and Bone Marrow Aspiration. Dr. Alpdogan is currently accepting new patients.

Husam Tarawneh is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Tarawneh is highly rated in 19 conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Tarawneh is board certified in American Board Of Internal Medicine, Hematology. Dr. Tarawneh is currently accepting new patients.

Bruce Kappel is a Hematologist and an Oncologist practicing medicine in Woodbury, New York. He has been practicing medicine for over 44 years. Dr. Kappel is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Adult Immune Thrombocytopenia, and Immune Thrombocytopenic Purpura (ITP). Dr. Kappel is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Kappel is currently accepting new patients.

Ajay Tadepalli is an Oncologist practicing medicine in Johns Creek, Georgia. Dr. Tadepalli is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Tadepalli is board certified in American Board Of Internal Medicine, 2014. Dr. Tadepalli is currently accepting new patients.

John Lech, DO, is a hematologist/medical oncologist at UPMC Hillman Cancer Center. He specializes in the treatment of gastrointestinal malignancies and peritoneal carcinomas. Dr. Lech is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma. Dr. Lech is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Lech is currently accepting new patients.

Harvey Hotchner is a Hematologist and an Oncologist practicing medicine in Hazleton, Pennsylvania. Dr. Hotchner is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Familial Pancreatic Cancer. Dr. Hotchner is board certified in American Board Of Internal Medicine - Medical Oncology and American Board Of Internal Medicine - Internal Medicine. Dr. Hotchner is currently accepting new patients.

Michael J. Schwartz, MD, is Chief of Urology at Long Island Jewish Medical Center and Director of Urology Services for Northwell Health's Central Region. Dr. Schwartz specializes in minimally invasive procedures to treat prostate cancer. He has vast experience in robotic-assisted radical prostatectomy, evolving surgical techniques over time to minimize treatment-related side effects. For qualifying prostate cancer patients, Dr. Schwartz also offers focal ablation therapies, using sophisticated image guidance and focal tissue ablation to eradicate prostate cancer with few side effects. He has additional expertise in urologic oncology and surgery to treat kidney, bladder, adrenal and testicular cancers. Becoming a doctor always felt natural to me, Dr. Schwartz says. I was always interested in helping others, and urology is a wonderful blend of both medical and surgical care, allowing for the development of long-term relationships with my patients. Dr. Schwartz earned his medical degree from Warren Alpert Medical School of Brown University and pursued his residency training in urology at New York-Presbyterian Hospital, Cornell. He received his fellowship training in advanced laparoscopic and endoscopic surgery at North Shore University Hospital and Long Island Jewish Medical Center. Dr. Schwartz values a team-based approach to care, working with radiologists, pathologists and medical oncologists to create individualized, evidence-based treatment plans. He also carefully listens to patients to meet their unique goals and preferences. In addition to treating prostate cancer, Dr. Schwartz is a pioneer in prostate cancer diagnosis. He was an early adopter of transperineal biopsy-which eliminates the infection risk associated with the prior transrectal method-and helped the Smith Institute of Urology transition to using that approach for all patients requiring prostate biopsy across Northwell Health. His research focuses on both diagnostics and treatment of prostate cancer, and he is involved with several clinical trials for focal therapy. He is a member of the American Urological Association and Society of Urologic Oncology. He is Associate Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. For Dr. Schwartz, one of the best parts of his job is getting to know his patients. I have the privilege of seeing their humanity, learning about their lives and discovering what's important to them, he says. Their experiences inspire me every day. Dr. Schwartz is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Reconstructive Urology Surgery, and Nephrectomy. Dr. Schwartz is board certified in American Board Of Urology. Dr. Schwartz is currently accepting new patients.

Dr. Hershman is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology, chief of the division of hematology/oncology, and deputy director of the Herbert Irving Comprehensive Cancer Center at Columbia University. She completed her medical degree at the Albert Einstein College of Medicine, and completed her internal medicine and oncology fellowship training at Columbia University Medical Center, where she served as Chief Resident. During that time she completed a Master's degree in Biostatistics at the Mailman School of Public Health. She has developed nationally recognized expertise in breast cancer treatment, prevention, and survivorship.Dr. Hershman has also developed a comprehensive multidisciplinary program to study ways of improving cancer care delivery (CCD), reducing disparities and designing studies to improve the quality of life and quality of care in breast cancer survivors. She has received funding from the American Society of Clinical Oncology, American Cancer Society, Department of Defense, Breast Cancer Research Foundation, PCORI, and the National Cancer Institute. She currently has mentored numerous faculty members who have been granted mentored career development awards, and has received the Women Who Conquer Cancer Mentorship Award and the CUIMC Mentor of the Year Award. Dr. Hershman has published over 450 scientific articles and has received several awards including the highly prestigious Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology, the Advanced Medical Achievement Award from the Avon Foundation and a Giants in Cancer Care Award.She has several national leadership roles in oncology. As vice chair of the SWOG Cancer Research Network she oversees the NCI's Community Oncology Research Programs (NCORP) research portfolio, which includes prevention and epidemiology, cancer care delivery, symptom control and quality of life, and survivorship trials. Within ASCO she was selected to participate in the first Leadership Development Program and has been the Chair of the Grants Selection Committee, Chair of the ASCO Quality Care Symposium and has been a member of multiple committees and task-forces. She is on the editorial board for the Journal of Clinical Oncology and is an Associate Editor at the Journal of the National Cancer Institute. Dr. Hershman is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Febrile Neutropenia, Inflammatory Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Hershman is board certified in Internal Medicine and Medical Oncology. Dr. Hershman is currently accepting new patients.

Robert Soiffer is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Soiffer is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Graft, and Tissue Biopsy. Dr. Soiffer is currently accepting new patients.

Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. Dr. Bahary is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Bahary is board certified in Medical Oncology, American Board Of Internal Medicine.

Dr. Punnen's research interest is in prostate cancer, primarily related to imaging, genomic, and molecular biomarkers in the detection, risk stratification, and monitoring of prostate cancer. Dr. Punnen is a lead investigator on two prospective clinical trials validating a novel blood-based biomarker called the 4KScore test for predicting the risk of clinically significant prostate cancer and need for biopsy of the prostate. He is also the Principal Investigator on an ongoing NCI funded prospective clinical trial examining the impact of prostate MRI and tissue based genomic prognostic signatures in men undergoing active surveillance for prostate cancer. Dr. Punnen is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy. Dr. Punnen is currently accepting new patients.

Christine Bestvina is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Bestvina is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), Tissue Biopsy, and Gastrostomy. Dr. Bestvina is board certified in Internal Medicine Medical Oncology and Practicing Since2018. Dr. Bestvina is currently accepting new patients.

Bonnie Glisson is an Oncologist practicing medicine in Cary, North Carolina. Dr. Glisson is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Nasopharyngeal Carcinoma, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Dr. Nataliya Mar is a board-certified UCI medical oncologist who specializes in genitourinary malignancies including prostate, bladder, renal and testicular cancer.Mar received her medical degree from SUNY Downstate Medical Center in New York City, N.Y., where she also completed a residency in internal medicine at Lenox Hill Hospital. Next she completed a fellowship in hematology and oncology at the University of Connecticut Health Center in Farmington, Conn.In addition to delivering patient care, Mar is involved in the design and supervising of clinical trials at the UCI Health Chao Family Comprehensive Cancer Center. She has published several articles in peer-reviewed journals related to her work. Dr. Mar is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), and Orchiectomy.

Francine Foss is an Oncologist practicing medicine in New Haven, Connecticut. She has been practicing medicine for over 44 years. Dr. Foss is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Cutaneous T-Cell Lymphoma (CTCL).

Thomas Reid is an Oncologist practicing medicine in Springfield, Ohio. Dr. Reid is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Lymphadenectomy, and Hernia Surgery. Dr. Reid is currently accepting new patients.

Nikolaos Papadantonakis is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. Dr. Papadantonakis is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Childhood Acute Myeloid Leukemia, and Bone Marrow Aspiration. Dr. Papadantonakis is currently accepting new patients.

Earle Burgess is an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Burgess is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Chromophobe Renal Cell Carcinoma. Dr. Burgess is board certified in American Board Of Internal Medicine, Hematology, American Board Of Internal Medicine, and American Board Of Internal Medicine, Medical Oncology. Dr. Burgess is currently accepting new patients.

Devalingam Mahalingam is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Mahalingam is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Colorectal Cancer, and Liver Embolization. Dr. Mahalingam is board certified in American Board Of Internal Medicine - Internal Medicine (Certified). Dr. Mahalingam is currently accepting new patients.

Samuel Haywood is an Oncologist practicing medicine in Mayfield Hts, Ohio. Dr. Haywood is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Haywood is board certified in American Board Of Urology, 2021. Dr. Haywood is currently accepting new patients.

David Altman is an Oncologist and a Urologist practicing medicine in Lansdale, Pennsylvania. Dr. Altman is highly rated in 18 conditions, according to our data. His clinical expertise encompasses UPJ Obstruction, Urinary Tract Infection in Children, Hydronephrosis, Ureteroscopy, and Bladder Reconstruction. Dr. Altman is board certified in Urology. Dr. Altman is currently accepting new patients.

Elena Susana Moore, MD, a gynecologic oncologist at Endeavor Health, provides expert care for patients with cancers of the female reproductive system. She treats conditions such as cervical, endometrial and ovarian cancer, and performs procedures including hysterectomy, cancer staging and chemotherapy. Dr. Moore works with multidisciplinary teams to guide patients through diagnosis, treatment and recovery. Dr. Moore is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Vulvar Cancer, and Cervical Cancer. Dr. Moore is board certified in American Board Of Obstetrics Gynecology. Dr. Moore is currently accepting new patients.

Judith Hopkins is an Oncologist practicing medicine in Kernersville, North Carolina. Dr. Hopkins is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Atypical Hemolytic Uremic Syndrome (aHUS), Paget Disease of the Breast, and Angiosarcoma. Dr. Hopkins is currently accepting new patients.

Brent Limbaugh is an Oncologist practicing medicine in North Augusta, South Carolina. Dr. Limbaugh is highly rated in 68 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Lung Cancer, Paget Disease of the Breast, and Pleuropulmonary Blastoma. Dr. Limbaugh is currently accepting new patients.